Trifork Group AG
Trifork subsidiary Nine wins framework agreement with Denmark’s National Agency for IT and Learning
Trifork subsidiary Nine wins framework agreement with Denmark’s National Agency for IT and Learning
Press release
Trifork subsidiary Nine wins framework agreement with Denmark’s National Agency for IT and Learning
Copenhagen, Denmark — January 23, 2026 — Trifork Group is pleased to announce that Nine A/S, a subsidiary company, has been awarded the LOD framework agreement (Login and Data Presentation) by the National Agency for IT and Learning (STIL) for the period 2026–2029.
The framework agreement covers seven applications supporting key digital services in Denmark’s education and employment ecosystem. The solutions include shared login capabilities and process support for a common data foundation related to young people’s education and employment. In addition, the agreement includes process support for granting permissions to send and retrieve data via STIL’s web services.
“We look forward to the next four years of exciting projects, and we want to thank STIL for their continued trust,” says Jacob Strange, CEO of Nine A/S.
About Trifork Group
Trifork (Nasdaq Copenhagen: TRIFOR) is a pioneering global technology company, empowering enterprise and public sector customers with innovative digital products and solutions. With 1,197 employees across 16 countries, Trifork specializes in designing, building, and operating advanced software in public administration, healthcare, financial services, manufacturing, energy, aviation, and retail. The Group’s R&D arm, Trifork Labs, drives innovation by investing in and developing synergistic, high-potential technology companies. Learn more at trifork.com.
Contact:
Frederik Svanholm, Group Investment Director, +41 79 357 7317, frsv@trifork.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alveus Therapeutics Inc23.1.2026 13:30:00 CET | Press release
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
LOWRISC C.I.C.23.1.2026 13:28:00 CET | Press release
OpenTitan Introduces New Membership Tiers and Deliverables to Accelerate Deployment
Investeringsforeningen C Worldwide23.1.2026 13:20:27 CET | Pressemeddelelse
Opdatering af forventede udbytter for regnskabsåret 2025
Plug Power, Inc.23.1.2026 13:00:00 CET | Press release
Plug Power Completes Installation of 100 MW GenEco Electrolyzer Units at Galp’s Sines Refinery
OKYO Pharma LTD23.1.2026 13:00:00 CET | Press release
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom